Profound Medical Investor Relations Material
Latest events
Q2 2024
Profound Medical
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Profound Medical Corp
Access all reports
Profound Medical Corp. is a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment. Their product portfolio includes, among other, the ULTRASONIC PEEL® system and products in development including the SONIFIBER® family of transradial endoluminal ultrasound fibers. The company's technologies are designed to offer doctors safe and effective options for patients as they seek improved treatments for their conditions.
Key slides for Profound Medical Corp
Investor Presentation
Profound Medical Corp
Investor Presentation
Profound Medical Corp
Latest articles
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
Ticker symbol
PROF
Country
🇺🇸 United States